“…[13] Finally, in 2005, Ishihara and co-workers reported a new methodology where retention of configuration at the threonine β-carbon to form the oxazoline was accessed after exposing the β-hydroxy amides under harsh conditions using molybdenum oxides as a catalyst in toluene. [14] These previous methodologies have been used to access multiple NPs, for example, fimsbactin A and B, [15] mycobactin J, [16] (R)-D-ornithine derivative BE-70016, [17] pseudobactin, [18] lissoclinamide, [19] leupyrrin B1, [20] madurastatin C1, [21] bistratamide D, [5] among others.…”